• OPEN AN ACCOUNT
Indian Indices
Sensex
77,540.83 3.11
( 0.00%)
Global Indices
Nasdaq
53,294.39 514.18
(0.97%)
Dow Jones
7,693.51 31.35
(0.41%)
Hang Seng
65,893.13 -323.66
(-0.49%)
Nikkei 225
10,809.01 60.85
(0.57%)
Forex
USD-INR
95.67 0.05
(0.05%)
EUR-INR
111.76 0.57
(0.51%)
GBP-INR
130.35 0.55
(0.42%)
JPY-INR
0.60 0.00
(0.11%)

EQUITY - MARKET SCREENER

Godavari Drugs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
530317
INE362C01012
71.053773
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
28.37
110.23
EPS(TTM)
Face Value()
Div & Yield %
3.56
10
0
 

Caprihans India consolidated net profit rises 211.50% in the March 2026 quarter
May 26,2026
Net profit of Caprihans India rose 211.50% to Rs 7.04 crore in the quarter ended March 2026 as against Rs 2.26 crore during the previous quarter ended March 2025. Sales declined 1.65% to Rs 180.11 crore in the quarter ended March 2026 as against Rs 183.13 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 47.00 crore in the year ended March 2026 as against net loss of Rs 62.67 crore during the previous year ended March 2025. Sales declined 4.87% to Rs 701.91 crore in the year ended March 2026 as against Rs 737.85 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales180.11183.13 -2 701.91737.85 -5
OPM %9.963.63 -5.944.99 -
PBDT18.10-7.78 LP -4.91-29.39 83
PBT6.96-18.81 LP -49.81-73.13 32
NP7.042.26 212 -47.00-62.67 25